Abstract:Background: Paclitaxel is a natural anticancer drug, which has demonstrated significant activity in clinical trials. However, it has been limited due to poor aqueous solubility. Chitosan can be modified into graft copolymer, which changed into nanoparticles in aqueous solution, and employed as controlled release carriers for drugs. Objective: To study the characterization, in addition, to evaluate in vitro drug release ability of paclitaxel nanoparticles. Design, time and setting: A repeated measurement design was conducted at the Laboratory of North China Coal Medical University from January 2008 to July 2008. Materials: The average molecular weight of 2.0 × 10 5 chitosan with 92% deacetylation degree was produced by Golden-shell Biochemical Co., Ltd. Paclitaxel (lot number: 082329802) was provided by National Institute for the Control of Pharmaceutical and Biological Products. Methods: The potassium diperiodaton-ickelate served as initiator, chitosan-graft-vinyl acetate copolymers were synthesized by free radical graft copolymerization, which could be directly transformed into nanoparticles with hydrophobic core and hydrophilic surface in the water medium. Paclitaxel nanopartioles were prepared via mixture 0.5-5.0 mg paclitaxel with nanoparticles by ultrasonic irradiation technology. Main outcome measures: Particles size, polydispersity index zeta potential was detected by laser particle size analyzer. The morphology of chitosan nanoparticles and paclitaxel nanoparticles was observed by transmission electron microscope. In addition, encapsulation capability, loading content and in vitro drug release of the paclitaxel nanoparticles was analyzed by high-performance liquid chromatography. Results: The mean diameters of chitosan nanoparticles and paclitaxel nanoparticles were 196.2 nm and 320.8 nm, respectively. The nanoparticles possessed a uniform particles size distribution and an obvious positive charge surface, but the Zeta potential had no significant difference (F=0.818, F=3.38, all P > 0.05). The dose of paclitaxel could affect the encapsulation rate, which could up to 93.6% when added the quantity of paclitaxel was 2% of anoparticles. The results of simulate drug release showed that drug release was reach 48.3% in 24 hours at the burst release phase, which up to 75.9% at 175 hours longer in the slower release phase. The encapsulation rate of drug-loaded nanoparticles was stable. Conclusion: The preparation method is reliable and simple. The nanoparticles possessed good physical performance and sustained release character in vitro.

Loading paclitaxel into porous starch in the form of nanoparticles to improve its dissolution and bioavailability.

Poly(ether-ester Anhydride)-Based Amphiphilic Block Copolymer Nanoparticle As Delivery Devices for Paclitaxel

Preparation and Characterization of Paclitaxel-Loaded DSPE-PEG-liquid Crystalline Nanoparticles (lcnps) for Improved Bioavailability

Preparation, characterization and drug release property of paclitaxel nanoparticles

Photo-crosslinked Poly(ethylene Glycol)-B-poly(ϵ-caprolactone) Nanoparticles for Controllable Paclitaxel Release

Preparation and Characterization of Paclitaxel Delivery System Based on Semi-Solid Lipid Nanoparticles Coated with Poly (ethylene Glycol).

Preparation and in Vitro Evaluation of Paclitaxel-Loaded Poly(lactide-co-glycolide) Nanoparticles

Characterization, Pharmacokinetics and Disposition of Novel Nanoscale Preparations of Paclitaxel.

Polysaccharide-coated porous starch-based oral carrier for paclitaxel: Adsorption and sustained release in colon

[Preparation and Drug Release Property of Paclitaxel Nanoparticles].

Preparation and Characterization of Paclitaxel Nanosuspension Using Novel Emulsification Method by Combining High Speed Homogenizer and High Pressure Homogenization

Colon targeted releases and uptakes of paclitaxel loaded in modified porous starch

A new water-soluble nano-micelle formulation of paclitaxel loaded in amphiphilic block copolymer

Formulation, Pharmacokinetic Evaluation and Cytotoxicity of an Enhanced- penetration Paclitaxel Nanosuspension.

A pre-formulation study of a polymeric solid dispersion of paclitaxel prepared using a quasi-emulsion solvent diffusion method to improve the oral bioavailability in rats

Folate-mediated solid-liquid lipid nanoparticles for paclitaxel-coated poly(ethylene glycol).

The Preparation, Characterization, and Pharmacokinetic Studies of Chitosan Nanoparticles Loaded with Paclitaxel/Dimethyl-Beta-Cyclodextrin Inclusion Complexes

Amphiphilic Nanoparticles Based on Poly(Vinyl Pyrrolidone) and Stearoyl Modified Chitosan As Drug Vehicles for Paclitaxel Delivery

Poly(Ester Anhydride)/Mpeg Amphiphilic Block Co-Polymer Nanoparticles As Delivery Devices For Paclitaxel

[Studies on Paclitaxel-Loaded Methoxy Poly (ethylene Glycol)/poly (L-Lactic Acid) Diblock Copolymer Nanoparticles].

Enhanced Oral Bioavailability of Paclitaxel Formulated in Vitamin E-TPGS Emulsified Nanoparticles of Biodegradable Polymers: in Vitro and in Vivo Studies